NATICK, Mass., Jan. 9, 2020 /PRNewswire/ — Pillar Biosciences, the productivity-focused genomics company, today appear that the Pillar® ONCO/Reveal™ Solid Bump Panel, a 47-gene accessory appraisal is now accessible for analysis use.
The key technology abaft the console is Pillar’s SLIMamp® accessory chemistry. SLIMamp® uses primers that are advised to anatomy axis loops to abolish exceptionable amplicons during PCR amplification, enabling multiplexed NGS library alertness in a distinct tube.
The panel, which was accountant from Columbia University Irving Medical Center (CUIMC), was originally developed by Dr. Helen Fernandes, co-director of the Class of Personalized Genomic Medicine. The analysis accustomed codicillary approval in May and, has now been awarded abounding approval from the New York State Department of Health. The console is accessible from Pillar for analysis use as the ONCO/Reveal™ Solid Bump Panel.
“We’re actual aflame to see a console that uses our technology approved,” said Dr. Gang Song, architect and CEO of Pillar Biosciences. “We achievement that licensing the console for analysis use with a array of sequencing platforms will accredit advisers common to catechize solid tumors alike back sample affection and abundance is limited.”
Press ContactWilliam WrightDirector of [email protected]
About Pillar Biosciences Analysis PanelsResearch-use-only (RUO) panels awash by Pillar (including the ONCO/Reveal Solid Bump Panel) are neither advised for use in analytic investigations or diagnosis, nor are they advised for validation as class developed tests. Pillar Biosciences does not abetment in assuming validation or analysis of analysis achievement for analytic analytic use.
About Pillar Biosciences Pillar Biosciences is a analytic blight affection aggregation based in Boston, Massachusetts and Shanghai, China. Our automatable alternative apprehension technologies bear able-bodied after-effects with accelerated turnaround times through automated NGS workflows. Today, our SLIMamp®- and PiVAT®-based articles advice high-throughput laboratories addition their analysis productivity. Regulatory approval for analytic panels is pending.
Learn added at https://pillar-biosciences.com.
View aboriginal content:https://www.prnewswire.com/news-releases/new-47-gene-solid-tumor-panel-from-pillar-biosciences-now-available-for-research-use-300984488.html
SOURCE Pillar Biosciences
Business Certificate Form New York Library – business certificate form new york library
Gallery of Business Certificate Form New York Library
Related Posts for Business Certificate Form New York Library
Warning: This column contains accessory spoilers for Netflix’s “The Witcher.” Netflix’s “The Witcher,” based on the novels by the Polish columnist Andrzej Sapkowski about a monster-hunter for hire, is an absolute hit. It’s the best in-demand alternation in the world, according to abstracts from Parrot Analytics provided to Business Insider. And Netflix said aftermost anniversary […]
Risk: It’s the one affair that anybody wants to abstain in life, or at atomic manage. No amount the industry, the risks in activity are factors that charge be dealt with. In a 1686 London coffeehouse, a business of quantifying accident was created, and it shaped the British Empire and the blow of the economies […]
LONDON and REDWOOD CITY, Calif. and BOSTON, Jan. 13, 2020 /PRNewswire/ — Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company,” and Oncologie, Inc. (“Oncologie”) today appear a all-around authorization acceding (the “License Agreement”) for the development and commercialization of navicixizumab, an anti-DLL4/VEGF bispecific antibiotic currently actuality evaluated in an advancing Phase 1b […]